☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Hepatitis C
AbbVie's Maviret (glecaprevir/pibrentasvir) Receives European Commission Approval for Treatment-Naive Patients with Chronic Hepati...
August 2, 2019
Louisiana Department of Health Launches Innovative Payment Model with Asegua Therapeutics to Eliminate Hepatitis C in Louisiana
June 27, 2019
AbbVie's Mavyret (glecaprevir and pibrentasvir) Receives FDA's Approval for All Genotypes of Hepatitis C in Pediatric Patients
May 1, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
